LUNG
CANCER
NURSING
UK
Expl￿1n8 the expÈiien(# and nEe*il
never 5moke5 With Lcitkwi
LUNG CANCÈ
'NURSING
Ihi
Annual Report and Accounts
Financial Year ending January 2026
li
ancer Nursing UK | FIFTEEN Ro5ehi
LSLE, CAI 2RW
Mqnt
te

Trustees, Report | For the year ending January 2026
About LCNUK
Lung Cancer Nursing UK was estabLished in 1998 to support the advancement of health by
providing nurses who specialise in the treatment of patients with Lung cancer or
mesothelioma with support, education and the opportunity to communicate and network
with peers.. and to provide a nationaL voice on clinical and strategic issues for specialist Lung
cancer nurses. The organisation became a charitable incorporated organisation (CIO) in 2015.
Membership is open to any specialist nurse who spends more than 50Vo of their working week
or clinical activities in caring for patients with lung cancer and or mesothelioma. Associate
membership is open to those who do not meet this criteria. The experience and clinical
background of the members working environments are very diverse, including, palliative care,
oncology (cancer centres or units) respiratory medicine, community and others, this affords
the organisation a wealth of knowledge in to which members can access.
The actlvltles of the CIO fall Into four dlstlnct categorfes these are as follow&
Clinical
Improving the care lung cancer patients receive
Disseminating best practice and sharing information and knowledge
DeveLopmental
Keeping members up-to-date with the latest Lung cancer news through our e-buLletins
Highlighting new developments in the UK
Encouraging regional participation within LCNUK
Education
Providing a forum to disseminate new developments, skills, treatments and practice
through educationaL programmes, annual conference, resources and pubLications
Sharing cLinical updates and best practice with members
Supporting and fostering audit and research in lung cancer and within the role of the
LCNS
Professional
Provid ing support and networking, infrastructure and opportunities
Campaigning for and supporting the role of the lung cancer nurse specialist
Providing a voice on clinical and strategic issue5.
H ighlighting the specialist role of nurses in cari ng for people with Lung cancer and
mesothelioma
Representing Lung cancer nurse speciaLists on nationaL and international bodies and
organ isations
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}

Trustees, Report | For the year ending January 2026
2025 Business Priorities
The Trustees present their annual report together with the f inancial statements of the charity
for the year l February 2025 to 31 January 2026. The Trustees confirm that the Annual Report
and Financial Statements of the charity comply with the current statutory requirements, the
requirements of the charity's governing document and the provisions of the Statement of
Recommended Practice (SORP) applicable to charities preparing thei r accounts in
accordance with the Financial Reporting Standard applicable in the UK and Republic of
IreLand {FRS102) (effective l January 2019).
The Trustees have complied with the duty in part I section 4 of the Charities Act 2011 to have
due regard to pubLic benefit guidance published by the Charity Commission. A detailed report
of the activities undertaken and achievements by the Charity to further its charitable
purposes for the public benef it is given below.
In 2025 LCNUK had the following business priorities:
ProfessionaL
To act as advocates for patients with lung cancer on national professionaL bodies such as
NICE/BTOG.
To represent the Lung cancer nurse specialist on professional bodies and committees and
provide a voice on strategic issues at a regional and national LeveL
To promote the Lung cancer nurse specialist role and its benefits on an internationaL platform.
To share best practice in lung cancer and mesothelioma care.
DeveLopmentaL
To ensure production and circulation of a monthLy e-bulleti n to share best practice and
highlight lung cancer and reLevant nursing news and events.
To maintain the LCNUK website creating, sharing and signposting to relevant news and
events.
Education and clinical
Annual Conference June 2025 - To provide ongoing professional education to Lung cancer
nurse speciaListS through its annual conference.
To provide regular educationaL programmes of activity for members and associate members.
Research
To support ongoing research programmes with academic institutions and provide small
research grants to support lung cancer nurse specialists taking their fi rst steps in research
and those seeking advanced care practitioner status.
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}

Trustees, Report | For the year ending January 2026
2025 Impact report
In 2025, workforce pressures continued relentlessly to impact on Lung Cancer Nurse
Specialists. The UK Lung Cancer CoaLition (UKLCC) reported in 2025 that the lung cancer
nurse specialist case Load typically ranges from 100 - 200 patients per nurse, and that this
level is insufficient to meet demand.
LCNUK has responded to these pressures by adapting its programmes and delivering
education through short-form digital content, webinars and podcasts to support ongoing
professional deveLopment. In spite of the challenges, the LCNUK annual conference
continued to be weLL attended and is seen as a highlight of the professional year for our
members.
In 2025, we introduced associate membership for lung cancer navigators and developed a
dedicated programme of education and practical tools to support this vital workforce
incLuding a professional framework to guide Lung Cancer Navigators/Coordinators, their line
managers and empLoyers on the core skiLLs, knowledge and training that they will gain and
demonstrate as they progress in the role. Navigators play a key role alongside lung cancer
nurse speciaLists in deliveri ng h igh-quality lung cancer care. They are an essentiaL part of the
pathway, helping to ensure that patients, needs are prioritised and that their care journey is
as seamless as possible.
Membership numbers have increased sLightly in the business year and continue to hoLd strong
following growth and increased retention after COVID. The charity is continuing to work on
deveLoping innovative programmes to attract new members.
Membership
2025
2024
2023
2022
2021
2020
2019
New
83
95
113
86
50.
82
Renewed
211
206
178
179
282.
156"
180
Expired/
cancelled
148
127
114
150
113
71
'Any member who paid for a membership in 2020, ha5 had their membership end dale extended to 2022
Professional
Influencing and contribution to national poLicy
LCNUK works alongside numerous organisations across the UK to inform lung cancer policy,
promote best practice and act as the patients advocate for people with Lung cancer.
In 2025, we continued to collaborate with national bodies including NICE, BTOG. UKLCC, Roy
Castle Lung Cancer Foundation and other lung cancer related organisations to support the
development of national policy and guideLines.
The organisation has continued to support Lung Cancer Europe activities which have had
number of initiatives taking pLace and members have submitted abstracts to the IASLC WorLd
Conference on Lung Cancer.
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}

Trustees, Report | For the year ending January 2026
Representation
British Thoracic Oncology Group
GlobaL Lung Cancer Coalition
I nternational Thoracic Oncology
Nurses Forum
Lung Cancer Europe
Mesothelioma UK
National Lung Cancer Audit
National Institute for Health and Care
Excellence
Roy Castle Lung Cancer CoaLition
Scottish Medicines Consortium
Scottish Lung Cancer Nurses Forum
UK Lung Cancer Coalition
Welsh Lung Cancer Nurses Forum
During 2025, LCNUK implemented a programme to evaLuate a tool to measure complexity in
patients with lung cancer. The tool was assessed by group of members as part of the LCNUK
annual workshop. The tool. based on The Patient Complexity Instrument" and the Macmillan
Palliative Care Concerns HNA,, demonstrated that complexity increases with cancer stage
and more nursing time is needed at stage 4. The strong correlation between emotional
domains and physical concerns emphasized the importance of addressing both needs. Whilst
the tooL does measure complexity, its value is limited in quantifying the appropriate nurse to
patient ratio for lung cancer nurse workforce planning. The results of the work was
presented at BTOG and LCNUK conferences and included in a lightning presentation at the
UKLCC conference.
DevelopmentaL
Leadership
Supported by a £5,000 educational grant from MSD, alongside £15,000 of LCNUK core funding, we
launched a new leadership programme at the end of 2024. This initiative provides lung cancer nurse
specialist member5 Wlth the opportunity to apply for funding to undertake NHS-approved leadership
development, including the Mary Seacole, Rosalind Franklin, and King's Fund leadership programmes.
These highLy respected courses enable members to build essential leadership capabilities such as
strategic thinking. influencing skills. service improvement. and leading teams through change. Three
members have successfully applied for the funding and are participating in the leadership
programmes.
By investing in leadership development. we aim to empower Lung cancer nurse specialists to drive
innovation, strengthen clinical service5. and enhance the qualily of care delivered across the Lung
cancer pathway.
hePatientCornplexilyln51rumentlvll. PresentedattheRCN InternationalRe5earch conlerence,UniversityolSouthWal￿. Easlerncooperative
OniologyGioup.In.d.l.ECOG PeiloimanieSlalu5ScaLe.
'MacmlllanCancerSupport.P0221. Concernslheckllsi- ideniifyingyourconcerns. Palllatlvecareconcerns HNAChe£kllst.Thomas,S.120181.
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011)

Trustees, Report | For the year ending January 2026
Education and clinical
In 2025, we hosted an annual conference at The Radisson Edwardian Hotel, Heathrow. The
conference attracted 327 attendees of which 129 were members of LCNUK. 96/0 of those who
completed the evaLuation reported that the conference was relevant to their educationaL
needs with similar numbers reporting that the information was well presented by
knowledgeable and appropriate speakers. When asked to describe their conference
experience delegates stated "informative" -educationaL". "interesting. -enjoyable",
"networking" "fun" and °inspiring" as the most commonLy used words.
The data represents a sLight improvement on the previous year. The conference was able to
raise much needed funds in 2025 (£176,633 vs £105,180 in 2024) from the saLe of exhibition
space.
The organisation hosted six webinars in 2025 supported by funding from Astrazeneca- which
members couLd attend Live or watch on-demand at their leisure. These incLuded:
The role of the multidisciplinary approach for
high risk lung cancer patients
2VOV2025
Charlotte Smith and
Vasileios Kouritas
TKI therapy in EGFR gene mutation lung
cancers/ Interpreting clinical trials
AListair Greystoke and
Jennifer Ross
27/02/2025
Key learning from the BTOG annual conference
2025
Paula Shepherd and
Shobhit Baijal
18/03/2025
Fit for Surgery Programme
29/04/2025
Babu Naidu and Bing
Smith
Small cell lung cancer
2210512025
Emma Halkyard and
Adam Uprichard
Considering and supporting the carers of
people with lung cancer
Julia McAdam and Nitin
Palekar
3V07/2025
-AslraZeneca had no Inputintothecontentolthewebinarsand5peaker5electionand editorialcontrol restedexclusivelywith LCNUK
In a bid to reach a wider pooL of Lung cancer nurses LCNUK aLso hosted the fi rst in a series of
planned annual regional meetings. This first meeting was heLd in Bristol where LCNUK has
identified a Lower ratio of members than other areas of the country. 41 individuals attended
with 21 delegates and 6 speakers. 2 registered delegates failed to attend. The meeting
sessions scored weLI for content and feedback was good.
I r*¢411 Èn
.J lém ,1
wsoré
lfy ,.{ d d-,pk
¢rÈw
IA
re
I ra
oc s édérx Pk.1 of
orL.,I Io s ¢ak lo kn.
Lfrsés
Ilgr of &l.yql Ik.¢
é5 ¢4
OrÈ IIMÈ for
¢4r
Ikrou
k Ig $ wÉlcOmÉ 9$ 1
COM
seÉ¥A$ lo bÉ 1￿Crè9$1NyY Fk. $0
re s¢55iOMs.
uÉ5
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}

Trustees, Report | For the year ending January 2026
Supported by funding from Astrazeneca LCNUK developed and impLemented an online
Learning module on biomarker testing in NSCLC. We also commenced the development of a
second Learning module on adverse event management of TKI toxicity which is due for
completion in Q2 2026. OnLine learning moduLes provide a valuable way for our members to
keep up to date with new practices and treatments and support ongoing professionaL
development in their own time. Records of all completed modules are retained and members
have the opportunity to download certificates of compLetion for thei r professionaL portfolios.
LCNUK continues to support the annual award to recognise achievements of members.
Communicating with our members
LCNUK has continued to deliver short form easiLy-to-access succinct communications with
members providing bite-size news and information that can be absorbed in the short window
of time available to our members. To do this we continue to use social media to push out key
messages, regularly update the content on our website with direct links from the home page
to key important lung cancer and nursing news. We aLso prepare and deliver a monthly
members newsletter featuring bite-size news and signposting members to educational and
professionaL development information as weLI as updates on key lung cancer news and Links
to other charity and not-for-profit news.
Specialist Groups- Research and Thoracic Surgery
LCNUK has two small workgroups of active members interested in research (known as RIG-
Research Interest Group} and thoracic surgery (TSG). In 2025, Bing Smith took over as research
lead of the RIG. CharLotte Smith continued to lead the TSG.
The RIG has been contributing to research projects and supporting access to clinical trials.
The group relaunched the small grants programme in 2025. Unfortunately, there have been
no eligible appLications. Following the annual meeti ng in 2025 the RIG are focusi ng on, with
the support of the Board of Trustees, the opportunity to develop a PhD programme and
support members who wish to take the first steps in research to support the research element
of the four nationally defined piLlars of advanced practice.
There is a focus on integrating the activities of the RIG through closer collaboration on the
annuaL workshop programme and other LCNUK activities.
27 abstracts were submitted to the LCNUK annual conference (vs 35 in 2024). Although this is
a slight decline on 2024 there has been a steady increase in submissions since COVID and this
remains signif icantly higher than pre-COVID years.
The TSG have focused their work on a review of performance status in lung cancer. The
outputs of their work have been shared through the Lung cancer community. The work
reported that HCPS rely i n performance status assessments to make important clinical
decisions but evidence suggests that there are newer tools which offer more objective,
continuous. and muLtidimensional assessment compared to traditional Performance Status
scales, but implementation chaLLenges remain around standardization, cost, and integration
into clinicaL workflows.

Trustees, Report | For the year ending January 2026
Plans for future periods
In 2026, LCNUK WILI be developing some new infographics to support nurses in the delivery of
core treatments and care.
We WILL be seeking to influence the national agenda to ensure that patients have appropriate
access to Lung cancer nurse speciaLists so that they can act as the patients, ambassador and
representative.
We will continue to disseminate and share the lung cancer nurse and navigator professional
frameworks which sets out the key skiLls and training required for the roles.
We wilL be undertaking a programme ofwork on the impact of the National Optimal Lung
cancer Pathway on lung cancer caseload for nurses.
A further regionaL meeting is planned for November 2026 in the eastern midLands region.
We are planning to introduce a "Nurse of the Year" award for members of LCNU
We will continue to explore how best to support, foster and harness research and audit by
Lung cancer nurse specialists and to share best practice and service development for the
benefit of peopLe with lung cancer.
We WILL support members who are working to achieve advanced clinical practitioner (ACP)
status through our programme of activities which support all four piLlars.
We WILL promote best practice through the sharing of cLinicaL knowledge and skills at our
annual flagship two-day conference in June 2026.
We will continue to work with partner organisations to promote best practice in Lung cancer
nursing.
We will continue to support member education with new online Learning modules, ongoing
webinars and other digital learning which are now an estabLished feature and benefit of
membership.
We will continue to promote member communications. the sharing and dissemination of
reLevant lung cancer news and information.
We will continue to act as patient representatives and advocates at a national policy leveL.
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}

Trustees, Report | For the year ending January 2026
Structure, Governance &
Management
Constitution
The charity is a registered charitable incorporated organisation, charity number 1160011.
Formal membership is open to any lung cancer nurse specialist who spends more than 50/0 of
their worki ng week or CLI n ical activities in caring for patients with lung cancer or
mesothelioma. In addition, membership is open to nurse specialists in a lung
cancer/mesothelioma academic or lung cancerlmesothelioma research role. Such
membership is subject to approval by the LCNUK Committee. Associate membership is open
to those who do not meet the criteria for formal membership.
Method of appointment and election of trustees
The management of the charity is the responsibility of the trustees who are elected and co-
opted under the terms of the constitution. During this period the LCNUK was managed by
seven trustees. Led by Diana Borthwick after being eLected the new chair by the board of
trustees. The trustees, or any member of LCNUK can recommend a trustee for appointment.
One third of the trustees retire each year and may be re-appointed. AppLicants are asked to
provide a CV and covering statement. A shortlist is drawn up and interviewed by a panel
appointed by the Board of Trustees. Four new trustees were co-opted by the board of
trustees in early 2026. Vanessa Beattie, Karen Clayton, Sian Evans and Lavinia Magee; these
ind ividuaLs wilL be put forward for election at the next annual general meeting of the charity.
The new trustees bring expertise in NHS and Lung cancer nursing and Sian Evans joins with
experience in human resources. John White and George Bate resigned in 2025.
Policies adopted for the induction and training of trustees
A trustee recruitment and induction pack is available to support new trustees i n learning
about the organisation, its role, governance and responsi bilities of trustees. LCNUK is also a
member of the National Council for VoLuntary Organisations to take advantage of
governance training opportunities. The charity are introducing a buddy scheme for new
trustees.
Organisation structure and decision making
The Trustees are assisted by the LCNUK Committee. The chair of the LCNUK committee
attend5 trustee meetings to ensure continuity and good communications. During 2025 the
committee was comprised of 13 elected members of LCNUK and three co-opted members.
The LCNUK committee is responsible for the operational delivery of programmes and aLso
formulates recommendations on the aims, strategies and activities of the charity for approval
by the trustees.
An agency, Red Hot Irons Limited (RHI), is contracted to run the day-to-day business
administration and operations of the organisation supervised by the LCNUK committee.
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}

Trustees, Report | For the year ending January 2026
Pay Policy for key management
There are no paid staff, all work undertaken by the committee and trustees is done so
voluntarily. The support agency is contracted to run the operationaL day-to-day activities and
business admi nistration.
AppLication and adherence to the Charity Governance Code
LCNUK recognise good governance is essential to our effectiveness, reputation and
credi bility. The Board of Trustees regularly review activitie5, policies and processes to ensure
the charity is delivering agai nst its mission and charitable objectives. We have robust
measures in pLace to ensure effective and clear overview of financial controls. The board
undertakes a regular review (every two years) of its effectiveness, assessing competencies,
skiLLs gaps and train ing needs through a process of external audit and facilitated discussion.
In 2025. LCNUK reviewed and updated its policies on privacy. safeguarding. antiharassment
and bullying, discipli nary procedure for members. bribery, compliants, conflicts of interest,
endorsement, procurement and representation. We also updated our poLicy for voLunteers.
The investment and risk management policies were also reviewed as part of the routine
governance of the organisation.
We operate a robust conflicts of interest policy, and all Trustees and Committee members
complete declarations of interest each year. Conflict of interests form a standing item on aLL
committee/board agendas. The Board aims to continuously improve its governance processes
and is currently working through the new Charity Governance Code to ensure its governance
structures adhere to the principles of the code and recommended practice.
While the charity receives funding and sponsorship from a range of pharmaceutical
companies and legal f i rms in the lung cancer field, the Board of Trustees undertakes regular
reviews to ensure that no single organisation exerts undue infLuence or creates an
over-reliance. We have clear and robust policies in place to safeguard our independence,
ensuring that all funding is accepted on the basis that it does not shape, compromise. or
jeopardise the i ntegrity of our work or the best interests of the people we serve.
Lung Cancer Nurslng
e Incorporated organisation (ClOI-
harity Number 116(M)11)

Trustees, Report | For the year ending January 2026
Risk management
The Trustees anaLyse and undertake a review of the risks the Charity is exposed to as part of
an annual business pLanning process and in accordance with Charity Commission guidar)ce
(CC26), scoring the risks according to li kelihood and impact. The systems and actions
established to mitigate those risk5 are also reviewed by Trustees at each Board meeting and
updated and adjusted accordingly, with the net risk in each area agreed. H igh risks closely
monitored by the Trustees are:
High LeveL of dependency on too few income streams puts LCNUK at risk of sudden
andlor Long-term loss of fundi ng- efforts continue to diversify income streams to incLude
more Trusts and Foundation as well as funding from non-pharmaceutical companies.
PotentiaL for a sudden drop in income and the need to dip into accumulated reserves
The risk that LCNUK could be perceived a5 being unduly influenced by.
sponsors/pharmaceuticaL industry. LCNUK has adopted a stringent endorsement policy
and ensures where possi bLe that there is a balance of sponsors from across the industry
spectrum with no one sponsor having significant influence or control. Sponsors are not
permitted to have any form of editoriaL control or influence over the content and
development of new LCNUK branded materiaLs.
Volunteers
The Society is heaviLy reLiant on the time, expertise and energy of its committee and other
members. Much of the work of the charity is conducted virtually via email and teleconference
and is undertaken on a voluntary basis.
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011)
io

Trustees, Report | For the year ending January 2026
Trustees, executive committee
& senior management
Tru5tee5
David BaLdwin
George Bate (resigned 0110912025)
Vanessa Beattie (co-opted Jan 2026)
Diana Borthwick (resigned 07/06/2026)
Karen CLayton (co-opted Jan 2026)
Lorraine Creech
Sian Evans (co-opted Jan 2026)
Nicola HandLey
Catherine Haywood
Lavinia Magee (co-opted Jan 2026)
Domin ic Smith (interim chair from 07106126)
John White (resigned 1110612025)
Registered office
c/0 Dodd & Co, FIFTEEN Rosehill
Montgomery Way
Roseh ILL Estate
CARLISLE
CAI 2RW
LCNUK Committee
Karen CLayton (resigned June 2025)
Pamela DalrympLe
Marie Eaton
Annabel Grinbergs (resigned May 2025)
Emma HaLkyard (resigned Dec 2025)
Maria Hill (elected October 2025)
Karen Macrae (elected October 2025)
Julia McAdam (Chair)
Venencia Rayson (elected October 2025)
Jenn ifer Ross
Paula Shepherd
Bing Smith
Charlotte Smith
Joanna Vick (elected October 2025)
Jane Weir
Kirstie Woods (elected October 2025,
resigned ApriL 2026)
Co-opted LCNUK Commillee members
Peter Barton (LGBTQIA representative)
Matthew KeLly (Nl representative)
Natalie Bloodworth (Wales representative)
Gemma Crowley (Wales representative)
Bankers
Unity Trust bank plc
Nine Brindley Place
Birmingham, Bl 2HB
Charity Bank
Fosse House, 182 High Street,
Tonbridge, Kent TN9 IBE
Charity Registered Number
1160011
Accountants
Dodd & Co Chartered Accountants
FI FTEEN RosehiLL
Morltgomery Way
RosehiLI Estate
Carlisle
CAI 2RW
Nationwide Building Society
Nationwide House, Pipers Way
Swindon, SN38 INW
Teachers BuiLding Society
Allenview House, Hanham Road
Wimborne, Dorset BH21 IAG
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}
li

Trustees, Report | For the year ending January 2026
Financial Review
PrincipaL Income
The principal fund ing sources for the Charity in 2025 as in previous years were..
Voluntary income from the pharmaceutical industry (fees from the LCNUK Corporate
Sponsorshi p)
Income f rom sponsorsh ip of charitable activities by commercial organisations
Membership fees and conference registrations
Total funding secured in 2025 was £255,052, an increase of 9.56Yo on the previous year.
ALthough the charity was only able to secure one corporate sponsorship during the
accounting period, add itional sponsorship for charitable activities helped offset this.
Increased income from bank interest (£19,820 compared with £6,808 in 2024), generated
through the introduction of new f ixed-rate accounts. also contributed to the overaLI upLift in
funding. Together, these factors enabled us to achieve higher income than in 2024.
Membership income (£8.400) was up on 2024 (£7.74fl) due to the increase in retention.
PrincipaL Expenditure
TotaL charitable expenditure in 2025 was £182.859, compared with £138,899 in 2024. This
increase refLects the growth in charitable activity, incLuding an increase in the number of
webinar5 delivered. additionaL online Learning modules produced. a new regional meeting
was held, increased travel bursaries awarded, and higher committee costs (the committee
has returned to face-to-face meetings rather than virtuaL formats). The national conference
was aLso significantly more expensive in 2025 than in 2024, driven by substantial rises in
venue fees that exceeded current inf lation rates.
Support costs have risen by £15,201 in the fiscal year to £33,913. The largest item in support
costs was secretariat, website and accountancy costs, which includes fees paid to Red Hot
Irons. Red Hot I rons is contracted to run the day-to-day operations of the charity, including
maintenance and upkeep of our website, membership management and communications,
committee management, events, IT, webinar5, anaLytics and database.
Reserves Policy
LCNUK has no regular or guaranteed sources of income, and the Long-term financial
sustainabi lity of the charity remains uncertain. Despite this, the charity must meet f ixed
operating costs to maintain its activities, fulf IL its charitabLe objectives, and sustain its
presence. Work is planned at least one year in advance, with some financiaL commitments -
such as those relating to the annual conference- made up to two years ahead.
The Trustees have therefore determined that, in order to safeguard the delivery of
programmes in the event of a significant reduction in income, the charity should hold an
opti mal reserve equivalent to 12 months of f ixed operating costs plus the annual cost of the
conference.
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011)
12

Trustees, Report | For the year ending January 2026
This level of reserve enables LCNU K to pursue its long-term strategy without being forced into
short-term reactive decisions during temporary funding deficits. It also provides the flexi bility
to take forward new opportunities that may require modest upfront investment. Minimum and
maximum reserve Levels have been set at six months and eighteen months of operating costs
respectively.
The Trustees will only consider taking significant corrective action if reserves fall below the
minimum threshoLd. and WILL onLy commit to major Long-term investments when reserves
exceed the optimaL leveL.
Based on the 2026 budget. the optimal reserve level is £226.664. with a minimum requirement
of £113,332. At the end of the accounting period (January 2026), the Society held free reserves
of £442,048, exceeding the optimal reserve target. The Board is now working with the
committee to identify new and appropriate charitabLe-purpose programmes that can be
supported using the surpLus reserves.
The Board undertakes an annual review of the reserves policy to ensure it remains aLigned
with the charity's activities and that the level of reserves is suff icient to meet f inancial and
charitable obligations should funding decline for any reason.
Going concern
After making appropriate enquiries. the Trustees have a reasonable expectation that the
charity has adequate resources to continue in operationaL existence for the foreseeabLe
future. For this reason, they continue to adopt the going concern basis in preparing the
financial statements. Further detaiLs regarding the adoption of the going concern basis can be
found in the accounting policies.
Financial Review Conclusion
The Society ended the year with an operating surplus of £38,280 for the accounting period.
The charity continues to hold healthy free reserves which exceed the maximum reserves Level
allowing the charity to undertake additional charitabLe programmes.
However, sponsorship and funding remain a significant challenge and operating costs
continue to rise particularly around venue hire charges and insurance costs. The Trustees
recognise that the funding situation remains chalLenging, and WILL continue to be innovative in
our approach to fundraising, cost savings and ensuring value for money. We WILL also Look to
achieve additionaL funding from grant making bodies.
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}
13

Trustees, Report | For the year ending January 2026
Statement of Trustees, responsibilities
The Trustees are responsibLe for preparing the Trustees, report and the financiaL statements in
accordance with applicable law and United Kingdom Accounting Standards (United Kingdom
Generally Accepted Accounting Practice).
Charity law requires the Trustees to prepare financial statements for each financiaL year.
Under charity law the Trustees must not approve the financial statements unless they are
satisfied that they give a true and fai r view of the state of affairs of the Charity and of its
incoming resources and application of resources, i ncluding its income and expenditure, for
that period. In preparing these financial statements, the Trustees are required to:
seLect suitabLe accounting policies and then apply them consistently:
observe the methods and principles of the Charities SORP (FRS 102)-
make judgments and accounting estimates that are reasonable and prudent,.
state whether applicable UK Accounting Standards {FRS 102) have been followed, subject
to any materiaL departures d isclosed and explained in the f inancial statements,.
prepare the financial statements on the going concern basis unless it is inappropriate to
presume that the charity will continue in business.
The Trustees are responsible for keeping adequate accounting records that are sufficient to
show and expLain the charity's transactions and discLose with reasonable accuracy at any time
the financiaL position of the charity and enabLe them to ensure that the f inancial statements
comply with the Charities Act 2011. They are aLso responsible for safeguarding the assets of
the charity and hence for taking reasonable steps for the prevention and detection of fraud
and other irreguLarities.
Disclosure of information to independent examiners
Each of the persons who are Trustees at the time when this Trustees, report is approved has
conf irmed that..
so far as that Trustee is aware, there is no relevant information of which the charity's
accountant and independent examiner are unaware, and
that Trustee has taken alL the steps that ought to have been taken as a Trustee in order to
be aware of any reLevant information and to establish that the charity's accountants are
aware of that information.
Approved by order of the members of the board of Trustees and signed on their behalf by..
Dominic Smith
Interim Chair of the Board of Trustees
Date..
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011)
14

## **Independent Examiner's Report to the Trustees of** 

## **Lung Cancer Nursing UK** 

I report on the accounts of the charity for the year ended 31 January 2026, which are set out on pages 16 to 23. 

Your attention is drawn to the fact that the Charity has prepared the financial statements in accordance with Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) in preference to the Accounting and Reporting by Charities: Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extant regulations but has since been withdrawn. 

We understand that this has been done in order for the accounts to provide a true and fair view in accordance with the Generally Accepted Accounting Practice effective for reporting periods beginning on or after 1 January 2019. 

## **Respective responsibilities of trustees and examiner** 

The Charity's trustees are responsible for the preparation of the accounts. The trustees consider that an audit is not required for this year under section 144(2) of the Charities Act 2011 as amended by the Charities Act 2022 (the Act) and that an independent examination is needed. 

The charity's gross income exceeded £250,000 and I am qualified to undertake the examination by being a qualified member of the Institute of Chartered Accountants in England and Wales. 

It is my responsibility to: 

- examine the accounts under section 145 of the Act; 

- follow the procedures laid down in the General Directions given by the Charity Commission under section 145 (5) (b) of the Act; and 

- state whether particular matters have come to my attention. 

## **Basis of independent examiner's report** 

My examination was carried out in accordance with the General Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts, and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit and consequently no opinion is given as to whether the accounts present a 'true and fair view' and the report is limited to those matters set out in the statement below. 

## **Independent examiner's statement** 

In connection with my examination, no matter has come to my attention: 

- (1) which gives me reasonable cause to believe that in any material respect the requirements: 

   - to keep accounting records in accordance with section 130 of the Charities Act 2011 as amended by the Charities Act 2022; and 

   - to prepare accounts which accord with the accounting records, comply with the accounting requirements of the Act 

have not been met; or 

- (2) to which, in my opinion, attention should be drawn in order to enable a proper understanding of the accounts to be reached. 


**----- Start of picture text -----**<br>
.........................................<br>**----- End of picture text -----**<br>


......................................... Joanne Thomlinson FCA Dodd & Co Limited Chartered Accountants 

FIFTEEN Rosehill Montgomery Way Rosehill Estate CARLISLE CA1 2RW 

26 May 2026 

Page 15 



Lung Cancer Nursing UK
known as
LCNUK
Statement of Financial Activities for the Year Ended 31 January 2026
Unrestricted Total Fund¥ Totsl Fund¥
Funds
2026
2025
Note
Income and endowments from:
Donations and legacies
Investtnenl income
Charitable activities
Total income
114
19,820
235.118
255,052
114
19,820
235.118
255.052
6,808
225.996
232,804
Expenditure on:
Ch8rit8ble activities
Total expenditure
216,772
216.772
216,772
218.772
157,611
157.611
Nel movements in funds
38,280
38,280
75,193
Reconciliation of funds
Total funds brought forward
Total funds carried forward
403,768
442,048
403,788
442,048
328,575
403,768
The notes on pages 18 10 24 form integral part of these fin8ncial staleTnent5.
Page 16

Lung Cancer Nursing UK
trading as
LCNUK
Balance Sheet as at 31 January 2026
2026
2025
Note
Current assets
Debtors
Cash at bank and in hand
10
49,693
442.451
58,401
375.181
492,144
433,582
Creditors.. Amounts falling du• within
one year
150,0961
{29,8141
Net current assets
442,048
403,768
Net assets
442,048
403,768
The funds of the charity=
Unrestricted funds
Unre51ricted income funds
442,048
403,768
Total charity funds
442,048
403,768
The financial statements have been prepared in accordance with the Financial Reporting Standard applicable in
the UK and Republic of Ireland IFRS 1021.
ApDroved by the Board on 26 May 2026 and signed on its behalf by..
D Smith
Trustee
The notes on pages 18 to 24 fomi an integral part of these financial ststements.
Page 17

Lung Cancer Nursing UK
known as
LCNUK
Notes to the Financial Statements for the Year Ended 31 January 2026
Accounting policies
Statèmant of eomplianeè
The accounts (financial statements) have been prepared under the historical cost convention with items
recognised at cost or transaction value unless otherwise stated in the relevant notelsl to these accounts.
The financial statements have been prepared in accordance wth the second edition of the Charities
Statement of Recommended Practice issued in October 2019, the Financial Reporting Standard applicable
in the United Kingdom and Republic of Ireland IFRS 1021 and the Charities Act 2011 as amended by the
Charities Act 2022.
The accounts Ifinancial statements) have been prepared to give a 'true and fairf view and have departed
from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a 'true
and fair view,. This departure has involved following Accounting and Reporting by Charities preparing their
accounts in accordan￿ with the Finanaal Reporting Standard applicable in the UK and Republic of Ireland
IFRS 1021 rather than the Accounting and Reporting by Charities'.Statement of Recommended Practice
effective from 1 April 2005 which has since been withdrawn.
Basis of preparation
The charity meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially
recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy
notes.
Going concern
These financial statements have been prepared on a going concern basis.The trustees assess whether the
use of going con￿rn is appropriate i.e. whether there are any material uncertainties related to events or
conditions that may cast significant doubt on the ability ol the Charity to continue as a going concern. The
trustees make this assessment in respect of a period of one year from the date of approval of the financial
statements.
Fund accounting policy
Unrestricted income funds are general funds that are available for use at the trustees, discretion in
furtherance of the objectives of the charity.
Further details ol each fund are disclosed in note 13.
Income and endowments
Donations and legacies induding gifts are recognised where there is entitlement, probability of receipt and
the amount can be measured with sufficient reliability.
Income frorn Goveinmenl and other grants, whelher'¢apilal' grants or'revenue, grants, is recognised when
the charity has entitlement to the fLJnd5. any performance conditions 8ttached to the grants have been mel,
It Is piobable th8t the incotne will be received and the atnount be rneasured reliably and 15 not deferred.
Investment income is recognised on a receivable basis.
Income from charitable activities includes income recognised as earned las the related goods or services
are provided) under contract.
Membership income is recognised in the period it relates to.
Page 18

Lung Cancer Nursing UK
known as
LCNUK
Notes to the Financial Statements for the Year Ended 31 January 2026
. conh"rtued
Expenditure
Liabilities are recognised as soon as there is a legal or constructive obligation committing the charity to the
expenditure. All expenditu￿ is accounted for on an accruals basis and has been dassrfied under headings
that aggregate all costs related to the category.
Expenditure on raising funds are the ￿sts of trading for fundraising purposes.
Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and
services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those
costs of an indirect nature necessary to support them.
Grants payable are payments made to third parties in the furtherance of the charitable objectives. Where
the charity gives a grant with conditions ft>r its payment being a speerfic level ol service or output to be
provided, such grants are only recognised in the SOFA once the reapient of the grant has provided the
specific service or output.
Grants payable without performance conditions are only recognised In the accounts when 8 Commitment
has been made and there are no conditions to be mel relating to the grant which rernain in the conliol of the
charity.
Provisions for grants are made when the intention lo m8ke a gr8nt has been communicated to the recipient
but there is uncertainty about either the timing of the grant or the amount of grant payable.
Support costs
Support costs include central functions and have been allocated to activity cost categories on a basis
consistent with the use of resources, for example. allocating propety costs by floor areas, or per c8Pita,
stsff costs by the lirne spent and other costs by their usage.
Irrecoverable VAT
Irrecoverable VAT is charged against the category of resources expended for which il was incurred.
Cash and Cash Equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-lemi highly liquid
investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of
change in value.
Restatement of comparatives
The charity has reclassified certain income items from donations and legacies to charitable activities
following a review of income presentation.
This is a disdosur&only change and does not affect total income, net rnovement in funds, or the charity's
financi81 position. Prior year comparatives have been reslaled accordingly lo ensure consistency wth the
current yearfs presentation.
Page 19

Lung Cancer Nursing UK
known as
LCNUK
Notes to the Financial Statements for the Year Ended 31 January 2026
. conh"rtued
Donatlons and legaeles
Unrestrictad Total Funds Total Funds
Funds
2026
2025
Donations and lègaciès
Donations
114
114
In¥astm•nt ineomè
Unr•striet•d Total Funds Total Funds
Funds
2026
2025
Interest on cash deposits
19,820
19.820
6,808
01 the investment income in 2025 £e,808 related to unrestricted funds.
Charitable activities
Unrestricted Total Funds Totsl Funds
Funds
2026
2025
Membershlp and research
Membership subscriptions
Corporate sponsorship
Regional incotne
Navigator group income
8,400
12.000
3,950
17
24,367
8,4QO
12.000
3,950
7,740
22.000
24.367
29,740
Annual conference
Conference sponsorship
collferen￿ exhibition only
Delegate registration
143,578
22,455
32.018
198,051
143.578
22,455
32,018
198,051
140,845
19,618
30,793
191,256
Online Education
Leadership programme income
Online Eduration Learning Modules
Webinar Sponsorship
5.000
7,700
5,000
12,700
7,700
5,000
12.700
5,000
235,118
235.118
225,996
Page 20

Lung Cancer Nursing UK
known as
LCNUK
Notes to the Financial Statements for the Year Ended 31 January 2026
. conh"rtued
Of the incorne from tharilable activities in 2025 £225,996 related lo unreslrided funds.
Expendlture
Membershlp
and
research
Annual
conference
Onllne
Educatlon
Total
2026
Total
2025
Direct costs
Grants payable- individuals
Webin81 Costs
Leadership progratnrne
expenditure
Metnber5hip administration costs
TSG committee costs
Website costs
N8vigalor group expenditure
RIG costs
Annual workshop
Online learning
Venue costs
Speaker costs and tokens
Management fees
Conlerence costs- materials
Conference costs- other
2,649
2.649
7,123
4,134
12,299
845
6.940
8,595
998
998
19841
5,846
4,455
12,533
1,061
4,328
570
1,936
8,333
2,708
43.664
3,444
11,500
20,068
19,437
138.899
7,123
4,134
12,299
845
6.940
8,595
998
998
80.559
80.559
2,946
12,000
23.724
19,049
182,859
12,000
23,724
19,049
140,927
30.675
11,257
Support costs
Insurance
Office management
Committee costs
Representation costs
Sundry expenses
Accountancy and bookkeeping
fees
Independent examinerfs fee
Bank charges
285
5,026
3.439
279
285
5,026
3,438
278
285
5,026
3,438
278
104
855
15,078
10,315
835
312
828
7,591
3,055
324
1.754
1,754
1.754
5.262
4,835
650
1,429
18,712
216
202
11,305
217
202
11,304
217
202
11,304
650
606
33,913
41,980
152,231
22,561
218,772
157,611
Of the total expendituie in 2025 £157,611 related to unrestricted funds.
Page 21

## **Lung Cancer Nursing UK known as LCNUK** 

## **Notes to the Financial Statements for the Year Ended 31 January 2026** 

_......... continued_ 

## **6 Grantmaking** 

## **Grants to individuals £** 

Annual conference 

2,649 

## **7 Trustees' remuneration and expenses** 

Committee meeting and travel expenses totalling £283 (2025: £387) were paid to 2 (2025: 4) of the trustees during the year. 

## **8 Taxation** 

The registered charity is exempt from taxation on income and gains. 

## **9 Debtors** 

|Trade debtors<br>Other debtors<br>Prepayments and accrued income|**2026**<br>**£**<br>22,774<br>1,140<br>25,779<br>49,693|**2025**<br>**£**<br>-<br>7,453<br>50,948|
|---|---|---|
|||58,401|



## **10 Creditors: Amounts falling due within one year** 

|Trade creditors<br>Other creditors<br>Accruals and deferred income|**2026**<br>**£**<br>2,664<br>-<br>47,432<br>50,096|**2025**<br>**£**<br>1,787<br>340<br>27,687|
|---|---|---|
|||29,814|



## **11 Related parties** 

## **Controlling entity** 

The charity is controlled by the trustees. 

Page 22 



## **Lung Cancer Nursing UK known as LCNUK** 

## **Notes to the Financial Statements for the Year Ended 31 January 2026** 

_......... continued_ 

## **12 Analysis of funds** 

|**General Funds**<br>Unrestricted income fund<br>**Prior year**<br>**General Funds**<br>Unrestricted income fund|**At 1**<br>**February**<br>**2025**<br>**Incoming**<br>**resources**<br>**Resources**<br>**expended**<br>**£**<br>**£**<br>**£**<br>403,768<br>255,052<br>(216,772)<br>**At 1**<br>**February**<br>**2024**<br>**Incoming**<br>**resources**<br>**Resources**<br>**expended**<br>**£**<br>**£**<br>**£**<br>328,575<br>232,804<br>(157,611)|**At 31**<br>**January 2026**<br>**£**<br>442,048|
|---|---|---|
|||**At 31**<br>**January 2025**<br>**£**<br>403,768|



## **13 Net assets by fund** 

|Current assets<br>Creditors: Amounts falling due within one year<br>Net assets<br>**Prior year**<br>Current assets<br>Creditors: Amounts falling due within one year<br>Net assets|**Unrestricted**<br>**Funds**<br>**£**<br>492,144<br>(50,096)<br>442,048<br>**Unrestricted**<br>**funds**<br>**£**<br>433,582<br>(29,814)<br>403,768|**Total Funds**<br>**2026**<br>**£**<br>492,144<br>(50,096)<br>442,048<br>**Total funds**<br>**2025**<br>**£**<br>433,582<br>(29,814)<br>403,768|**Total Funds**<br>**2025**<br>**£**<br>433,582<br>(29,814)<br>403,768<br>**Total funds**<br>**2024**<br>**£**<br>386,310<br>(57,735)<br>328,575|
|---|---|---|---|



Page 23 



LUNG
CANCER
NURSING
UK
WWW.LCNUK.ORG
Phone: 01675 477607
EmaiL' info@lcnuk.org
Correspondence address:
483 Green Lanes
London
N13 4BS
•V
Lung Cancer Nursing UK is a charitable incorporated organisation
Charity number 1160011

LUNG
CANCER
NURSING
UK
Expl￿1n8 the expÈiien(# and nEe*il
never 5moke5 With Lcitkwi
LUNG CANCÈ
'NURSING
Ihi
Annual Report and Accounts
Financial Year ending January 2026
li
ancer Nursing UK | FIFTEEN Ro5ehi
LSLE, CAI 2RW
Mqnt
te

Trustees, Report | For the year ending January 2026
About LCNUK
Lung Cancer Nursing UK was estabLished in 1998 to support the advancement of health by
providing nurses who specialise in the treatment of patients with Lung cancer or
mesothelioma with support, education and the opportunity to communicate and network
with peers.. and to provide a nationaL voice on clinical and strategic issues for specialist Lung
cancer nurses. The organisation became a charitable incorporated organisation (CIO) in 2015.
Membership is open to any specialist nurse who spends more than 50Vo of their working week
or clinical activities in caring for patients with lung cancer and or mesothelioma. Associate
membership is open to those who do not meet this criteria. The experience and clinical
background of the members working environments are very diverse, including, palliative care,
oncology (cancer centres or units) respiratory medicine, community and others, this affords
the organisation a wealth of knowledge in to which members can access.
The actlvltles of the CIO fall Into four dlstlnct categorfes these are as follow&
Clinical
Improving the care lung cancer patients receive
Disseminating best practice and sharing information and knowledge
DeveLopmental
Keeping members up-to-date with the latest Lung cancer news through our e-buLletins
Highlighting new developments in the UK
Encouraging regional participation within LCNUK
Education
Providing a forum to disseminate new developments, skills, treatments and practice
through educationaL programmes, annual conference, resources and pubLications
Sharing cLinical updates and best practice with members
Supporting and fostering audit and research in lung cancer and within the role of the
LCNS
Professional
Provid ing support and networking, infrastructure and opportunities
Campaigning for and supporting the role of the lung cancer nurse specialist
Providing a voice on clinical and strategic issue5.
H ighlighting the specialist role of nurses in cari ng for people with Lung cancer and
mesothelioma
Representing Lung cancer nurse speciaLists on nationaL and international bodies and
organ isations
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}

Trustees, Report | For the year ending January 2026
2025 Business Priorities
The Trustees present their annual report together with the f inancial statements of the charity
for the year l February 2025 to 31 January 2026. The Trustees confirm that the Annual Report
and Financial Statements of the charity comply with the current statutory requirements, the
requirements of the charity's governing document and the provisions of the Statement of
Recommended Practice (SORP) applicable to charities preparing thei r accounts in
accordance with the Financial Reporting Standard applicable in the UK and Republic of
IreLand {FRS102) (effective l January 2019).
The Trustees have complied with the duty in part I section 4 of the Charities Act 2011 to have
due regard to pubLic benefit guidance published by the Charity Commission. A detailed report
of the activities undertaken and achievements by the Charity to further its charitable
purposes for the public benef it is given below.
In 2025 LCNUK had the following business priorities:
ProfessionaL
To act as advocates for patients with lung cancer on national professionaL bodies such as
NICE/BTOG.
To represent the Lung cancer nurse specialist on professional bodies and committees and
provide a voice on strategic issues at a regional and national LeveL
To promote the Lung cancer nurse specialist role and its benefits on an internationaL platform.
To share best practice in lung cancer and mesothelioma care.
DeveLopmentaL
To ensure production and circulation of a monthLy e-bulleti n to share best practice and
highlight lung cancer and reLevant nursing news and events.
To maintain the LCNUK website creating, sharing and signposting to relevant news and
events.
Education and clinical
Annual Conference June 2025 - To provide ongoing professional education to Lung cancer
nurse speciaListS through its annual conference.
To provide regular educationaL programmes of activity for members and associate members.
Research
To support ongoing research programmes with academic institutions and provide small
research grants to support lung cancer nurse specialists taking their fi rst steps in research
and those seeking advanced care practitioner status.
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}

Trustees, Report | For the year ending January 2026
2025 Impact report
In 2025, workforce pressures continued relentlessly to impact on Lung Cancer Nurse
Specialists. The UK Lung Cancer CoaLition (UKLCC) reported in 2025 that the lung cancer
nurse specialist case Load typically ranges from 100 - 200 patients per nurse, and that this
level is insufficient to meet demand.
LCNUK has responded to these pressures by adapting its programmes and delivering
education through short-form digital content, webinars and podcasts to support ongoing
professional deveLopment. In spite of the challenges, the LCNUK annual conference
continued to be weLL attended and is seen as a highlight of the professional year for our
members.
In 2025, we introduced associate membership for lung cancer navigators and developed a
dedicated programme of education and practical tools to support this vital workforce
incLuding a professional framework to guide Lung Cancer Navigators/Coordinators, their line
managers and empLoyers on the core skiLLs, knowledge and training that they will gain and
demonstrate as they progress in the role. Navigators play a key role alongside lung cancer
nurse speciaLists in deliveri ng h igh-quality lung cancer care. They are an essentiaL part of the
pathway, helping to ensure that patients, needs are prioritised and that their care journey is
as seamless as possible.
Membership numbers have increased sLightly in the business year and continue to hoLd strong
following growth and increased retention after COVID. The charity is continuing to work on
deveLoping innovative programmes to attract new members.
Membership
2025
2024
2023
2022
2021
2020
2019
New
83
95
113
86
50.
82
Renewed
211
206
178
179
282.
156"
180
Expired/
cancelled
148
127
114
150
113
71
'Any member who paid for a membership in 2020, ha5 had their membership end dale extended to 2022
Professional
Influencing and contribution to national poLicy
LCNUK works alongside numerous organisations across the UK to inform lung cancer policy,
promote best practice and act as the patients advocate for people with Lung cancer.
In 2025, we continued to collaborate with national bodies including NICE, BTOG. UKLCC, Roy
Castle Lung Cancer Foundation and other lung cancer related organisations to support the
development of national policy and guideLines.
The organisation has continued to support Lung Cancer Europe activities which have had
number of initiatives taking pLace and members have submitted abstracts to the IASLC WorLd
Conference on Lung Cancer.
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}

Trustees, Report | For the year ending January 2026
Representation
British Thoracic Oncology Group
GlobaL Lung Cancer Coalition
I nternational Thoracic Oncology
Nurses Forum
Lung Cancer Europe
Mesothelioma UK
National Lung Cancer Audit
National Institute for Health and Care
Excellence
Roy Castle Lung Cancer CoaLition
Scottish Medicines Consortium
Scottish Lung Cancer Nurses Forum
UK Lung Cancer Coalition
Welsh Lung Cancer Nurses Forum
During 2025, LCNUK implemented a programme to evaLuate a tool to measure complexity in
patients with lung cancer. The tool was assessed by group of members as part of the LCNUK
annual workshop. The tool. based on The Patient Complexity Instrument" and the Macmillan
Palliative Care Concerns HNA,, demonstrated that complexity increases with cancer stage
and more nursing time is needed at stage 4. The strong correlation between emotional
domains and physical concerns emphasized the importance of addressing both needs. Whilst
the tooL does measure complexity, its value is limited in quantifying the appropriate nurse to
patient ratio for lung cancer nurse workforce planning. The results of the work was
presented at BTOG and LCNUK conferences and included in a lightning presentation at the
UKLCC conference.
DevelopmentaL
Leadership
Supported by a £5,000 educational grant from MSD, alongside £15,000 of LCNUK core funding, we
launched a new leadership programme at the end of 2024. This initiative provides lung cancer nurse
specialist member5 Wlth the opportunity to apply for funding to undertake NHS-approved leadership
development, including the Mary Seacole, Rosalind Franklin, and King's Fund leadership programmes.
These highLy respected courses enable members to build essential leadership capabilities such as
strategic thinking. influencing skills. service improvement. and leading teams through change. Three
members have successfully applied for the funding and are participating in the leadership
programmes.
By investing in leadership development. we aim to empower Lung cancer nurse specialists to drive
innovation, strengthen clinical service5. and enhance the qualily of care delivered across the Lung
cancer pathway.
hePatientCornplexilyln51rumentlvll. PresentedattheRCN InternationalRe5earch conlerence,UniversityolSouthWal￿. Easlerncooperative
OniologyGioup.In.d.l.ECOG PeiloimanieSlalu5ScaLe.
'MacmlllanCancerSupport.P0221. Concernslheckllsi- ideniifyingyourconcerns. Palllatlvecareconcerns HNAChe£kllst.Thomas,S.120181.
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011)

Trustees, Report | For the year ending January 2026
Education and clinical
In 2025, we hosted an annual conference at The Radisson Edwardian Hotel, Heathrow. The
conference attracted 327 attendees of which 129 were members of LCNUK. 96/0 of those who
completed the evaLuation reported that the conference was relevant to their educationaL
needs with similar numbers reporting that the information was well presented by
knowledgeable and appropriate speakers. When asked to describe their conference
experience delegates stated "informative" -educationaL". "interesting. -enjoyable",
"networking" "fun" and °inspiring" as the most commonLy used words.
The data represents a sLight improvement on the previous year. The conference was able to
raise much needed funds in 2025 (£176,633 vs £105,180 in 2024) from the saLe of exhibition
space.
The organisation hosted six webinars in 2025 supported by funding from Astrazeneca- which
members couLd attend Live or watch on-demand at their leisure. These incLuded:
The role of the multidisciplinary approach for
high risk lung cancer patients
2VOV2025
Charlotte Smith and
Vasileios Kouritas
TKI therapy in EGFR gene mutation lung
cancers/ Interpreting clinical trials
AListair Greystoke and
Jennifer Ross
27/02/2025
Key learning from the BTOG annual conference
2025
Paula Shepherd and
Shobhit Baijal
18/03/2025
Fit for Surgery Programme
29/04/2025
Babu Naidu and Bing
Smith
Small cell lung cancer
2210512025
Emma Halkyard and
Adam Uprichard
Considering and supporting the carers of
people with lung cancer
Julia McAdam and Nitin
Palekar
3V07/2025
-AslraZeneca had no Inputintothecontentolthewebinarsand5peaker5electionand editorialcontrol restedexclusivelywith LCNUK
In a bid to reach a wider pooL of Lung cancer nurses LCNUK aLso hosted the fi rst in a series of
planned annual regional meetings. This first meeting was heLd in Bristol where LCNUK has
identified a Lower ratio of members than other areas of the country. 41 individuals attended
with 21 delegates and 6 speakers. 2 registered delegates failed to attend. The meeting
sessions scored weLI for content and feedback was good.
I r*¢411 Èn
.J lém ,1
wsoré
lfy ,.{ d d-,pk
¢rÈw
IA
re
I ra
oc s édérx Pk.1 of
orL.,I Io s ¢ak lo kn.
Lfrsés
Ilgr of &l.yql Ik.¢
é5 ¢4
OrÈ IIMÈ for
¢4r
Ikrou
k Ig $ wÉlcOmÉ 9$ 1
COM
seÉ¥A$ lo bÉ 1￿Crè9$1NyY Fk. $0
re s¢55iOMs.
uÉ5
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}

Trustees, Report | For the year ending January 2026
Supported by funding from Astrazeneca LCNUK developed and impLemented an online
Learning module on biomarker testing in NSCLC. We also commenced the development of a
second Learning module on adverse event management of TKI toxicity which is due for
completion in Q2 2026. OnLine learning moduLes provide a valuable way for our members to
keep up to date with new practices and treatments and support ongoing professionaL
development in their own time. Records of all completed modules are retained and members
have the opportunity to download certificates of compLetion for thei r professionaL portfolios.
LCNUK continues to support the annual award to recognise achievements of members.
Communicating with our members
LCNUK has continued to deliver short form easiLy-to-access succinct communications with
members providing bite-size news and information that can be absorbed in the short window
of time available to our members. To do this we continue to use social media to push out key
messages, regularly update the content on our website with direct links from the home page
to key important lung cancer and nursing news. We aLso prepare and deliver a monthly
members newsletter featuring bite-size news and signposting members to educational and
professionaL development information as weLI as updates on key lung cancer news and Links
to other charity and not-for-profit news.
Specialist Groups- Research and Thoracic Surgery
LCNUK has two small workgroups of active members interested in research (known as RIG-
Research Interest Group} and thoracic surgery (TSG). In 2025, Bing Smith took over as research
lead of the RIG. CharLotte Smith continued to lead the TSG.
The RIG has been contributing to research projects and supporting access to clinical trials.
The group relaunched the small grants programme in 2025. Unfortunately, there have been
no eligible appLications. Following the annual meeti ng in 2025 the RIG are focusi ng on, with
the support of the Board of Trustees, the opportunity to develop a PhD programme and
support members who wish to take the first steps in research to support the research element
of the four nationally defined piLlars of advanced practice.
There is a focus on integrating the activities of the RIG through closer collaboration on the
annuaL workshop programme and other LCNUK activities.
27 abstracts were submitted to the LCNUK annual conference (vs 35 in 2024). Although this is
a slight decline on 2024 there has been a steady increase in submissions since COVID and this
remains signif icantly higher than pre-COVID years.
The TSG have focused their work on a review of performance status in lung cancer. The
outputs of their work have been shared through the Lung cancer community. The work
reported that HCPS rely i n performance status assessments to make important clinical
decisions but evidence suggests that there are newer tools which offer more objective,
continuous. and muLtidimensional assessment compared to traditional Performance Status
scales, but implementation chaLLenges remain around standardization, cost, and integration
into clinicaL workflows.

Trustees, Report | For the year ending January 2026
Plans for future periods
In 2026, LCNUK WILI be developing some new infographics to support nurses in the delivery of
core treatments and care.
We WILL be seeking to influence the national agenda to ensure that patients have appropriate
access to Lung cancer nurse speciaLists so that they can act as the patients, ambassador and
representative.
We will continue to disseminate and share the lung cancer nurse and navigator professional
frameworks which sets out the key skiLls and training required for the roles.
We wilL be undertaking a programme ofwork on the impact of the National Optimal Lung
cancer Pathway on lung cancer caseload for nurses.
A further regionaL meeting is planned for November 2026 in the eastern midLands region.
We are planning to introduce a "Nurse of the Year" award for members of LCNU
We will continue to explore how best to support, foster and harness research and audit by
Lung cancer nurse specialists and to share best practice and service development for the
benefit of peopLe with lung cancer.
We WILL support members who are working to achieve advanced clinical practitioner (ACP)
status through our programme of activities which support all four piLlars.
We WILL promote best practice through the sharing of cLinicaL knowledge and skills at our
annual flagship two-day conference in June 2026.
We will continue to work with partner organisations to promote best practice in Lung cancer
nursing.
We will continue to support member education with new online Learning modules, ongoing
webinars and other digital learning which are now an estabLished feature and benefit of
membership.
We will continue to promote member communications. the sharing and dissemination of
reLevant lung cancer news and information.
We will continue to act as patient representatives and advocates at a national policy leveL.
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}

Trustees, Report | For the year ending January 2026
Structure, Governance &
Management
Constitution
The charity is a registered charitable incorporated organisation, charity number 1160011.
Formal membership is open to any lung cancer nurse specialist who spends more than 50/0 of
their worki ng week or CLI n ical activities in caring for patients with lung cancer or
mesothelioma. In addition, membership is open to nurse specialists in a lung
cancer/mesothelioma academic or lung cancerlmesothelioma research role. Such
membership is subject to approval by the LCNUK Committee. Associate membership is open
to those who do not meet the criteria for formal membership.
Method of appointment and election of trustees
The management of the charity is the responsibility of the trustees who are elected and co-
opted under the terms of the constitution. During this period the LCNUK was managed by
seven trustees. Led by Diana Borthwick after being eLected the new chair by the board of
trustees. The trustees, or any member of LCNUK can recommend a trustee for appointment.
One third of the trustees retire each year and may be re-appointed. AppLicants are asked to
provide a CV and covering statement. A shortlist is drawn up and interviewed by a panel
appointed by the Board of Trustees. Four new trustees were co-opted by the board of
trustees in early 2026. Vanessa Beattie, Karen Clayton, Sian Evans and Lavinia Magee; these
ind ividuaLs wilL be put forward for election at the next annual general meeting of the charity.
The new trustees bring expertise in NHS and Lung cancer nursing and Sian Evans joins with
experience in human resources. John White and George Bate resigned in 2025.
Policies adopted for the induction and training of trustees
A trustee recruitment and induction pack is available to support new trustees i n learning
about the organisation, its role, governance and responsi bilities of trustees. LCNUK is also a
member of the National Council for VoLuntary Organisations to take advantage of
governance training opportunities. The charity are introducing a buddy scheme for new
trustees.
Organisation structure and decision making
The Trustees are assisted by the LCNUK Committee. The chair of the LCNUK committee
attend5 trustee meetings to ensure continuity and good communications. During 2025 the
committee was comprised of 13 elected members of LCNUK and three co-opted members.
The LCNUK committee is responsible for the operational delivery of programmes and aLso
formulates recommendations on the aims, strategies and activities of the charity for approval
by the trustees.
An agency, Red Hot Irons Limited (RHI), is contracted to run the day-to-day business
administration and operations of the organisation supervised by the LCNUK committee.
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}

Trustees, Report | For the year ending January 2026
Pay Policy for key management
There are no paid staff, all work undertaken by the committee and trustees is done so
voluntarily. The support agency is contracted to run the operationaL day-to-day activities and
business admi nistration.
AppLication and adherence to the Charity Governance Code
LCNUK recognise good governance is essential to our effectiveness, reputation and
credi bility. The Board of Trustees regularly review activitie5, policies and processes to ensure
the charity is delivering agai nst its mission and charitable objectives. We have robust
measures in pLace to ensure effective and clear overview of financial controls. The board
undertakes a regular review (every two years) of its effectiveness, assessing competencies,
skiLLs gaps and train ing needs through a process of external audit and facilitated discussion.
In 2025. LCNUK reviewed and updated its policies on privacy. safeguarding. antiharassment
and bullying, discipli nary procedure for members. bribery, compliants, conflicts of interest,
endorsement, procurement and representation. We also updated our poLicy for voLunteers.
The investment and risk management policies were also reviewed as part of the routine
governance of the organisation.
We operate a robust conflicts of interest policy, and all Trustees and Committee members
complete declarations of interest each year. Conflict of interests form a standing item on aLL
committee/board agendas. The Board aims to continuously improve its governance processes
and is currently working through the new Charity Governance Code to ensure its governance
structures adhere to the principles of the code and recommended practice.
While the charity receives funding and sponsorship from a range of pharmaceutical
companies and legal f i rms in the lung cancer field, the Board of Trustees undertakes regular
reviews to ensure that no single organisation exerts undue infLuence or creates an
over-reliance. We have clear and robust policies in place to safeguard our independence,
ensuring that all funding is accepted on the basis that it does not shape, compromise. or
jeopardise the i ntegrity of our work or the best interests of the people we serve.
Lung Cancer Nurslng
e Incorporated organisation (ClOI-
harity Number 116(M)11)

Trustees, Report | For the year ending January 2026
Risk management
The Trustees anaLyse and undertake a review of the risks the Charity is exposed to as part of
an annual business pLanning process and in accordance with Charity Commission guidar)ce
(CC26), scoring the risks according to li kelihood and impact. The systems and actions
established to mitigate those risk5 are also reviewed by Trustees at each Board meeting and
updated and adjusted accordingly, with the net risk in each area agreed. H igh risks closely
monitored by the Trustees are:
High LeveL of dependency on too few income streams puts LCNUK at risk of sudden
andlor Long-term loss of fundi ng- efforts continue to diversify income streams to incLude
more Trusts and Foundation as well as funding from non-pharmaceutical companies.
PotentiaL for a sudden drop in income and the need to dip into accumulated reserves
The risk that LCNUK could be perceived a5 being unduly influenced by.
sponsors/pharmaceuticaL industry. LCNUK has adopted a stringent endorsement policy
and ensures where possi bLe that there is a balance of sponsors from across the industry
spectrum with no one sponsor having significant influence or control. Sponsors are not
permitted to have any form of editoriaL control or influence over the content and
development of new LCNUK branded materiaLs.
Volunteers
The Society is heaviLy reLiant on the time, expertise and energy of its committee and other
members. Much of the work of the charity is conducted virtually via email and teleconference
and is undertaken on a voluntary basis.
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011)
io

Trustees, Report | For the year ending January 2026
Trustees, executive committee
& senior management
Tru5tee5
David BaLdwin
George Bate (resigned 0110912025)
Vanessa Beattie (co-opted Jan 2026)
Diana Borthwick (resigned 07/06/2026)
Karen CLayton (co-opted Jan 2026)
Lorraine Creech
Sian Evans (co-opted Jan 2026)
Nicola HandLey
Catherine Haywood
Lavinia Magee (co-opted Jan 2026)
Domin ic Smith (interim chair from 07106126)
John White (resigned 1110612025)
Registered office
c/0 Dodd & Co, FIFTEEN Rosehill
Montgomery Way
Roseh ILL Estate
CARLISLE
CAI 2RW
LCNUK Committee
Karen CLayton (resigned June 2025)
Pamela DalrympLe
Marie Eaton
Annabel Grinbergs (resigned May 2025)
Emma HaLkyard (resigned Dec 2025)
Maria Hill (elected October 2025)
Karen Macrae (elected October 2025)
Julia McAdam (Chair)
Venencia Rayson (elected October 2025)
Jenn ifer Ross
Paula Shepherd
Bing Smith
Charlotte Smith
Joanna Vick (elected October 2025)
Jane Weir
Kirstie Woods (elected October 2025,
resigned ApriL 2026)
Co-opted LCNUK Commillee members
Peter Barton (LGBTQIA representative)
Matthew KeLly (Nl representative)
Natalie Bloodworth (Wales representative)
Gemma Crowley (Wales representative)
Bankers
Unity Trust bank plc
Nine Brindley Place
Birmingham, Bl 2HB
Charity Bank
Fosse House, 182 High Street,
Tonbridge, Kent TN9 IBE
Charity Registered Number
1160011
Accountants
Dodd & Co Chartered Accountants
FI FTEEN RosehiLL
Morltgomery Way
RosehiLI Estate
Carlisle
CAI 2RW
Nationwide Building Society
Nationwide House, Pipers Way
Swindon, SN38 INW
Teachers BuiLding Society
Allenview House, Hanham Road
Wimborne, Dorset BH21 IAG
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}
li

Trustees, Report | For the year ending January 2026
Financial Review
PrincipaL Income
The principal fund ing sources for the Charity in 2025 as in previous years were..
Voluntary income from the pharmaceutical industry (fees from the LCNUK Corporate
Sponsorshi p)
Income f rom sponsorsh ip of charitable activities by commercial organisations
Membership fees and conference registrations
Total funding secured in 2025 was £255,052, an increase of 9.56Yo on the previous year.
ALthough the charity was only able to secure one corporate sponsorship during the
accounting period, add itional sponsorship for charitable activities helped offset this.
Increased income from bank interest (£19,820 compared with £6,808 in 2024), generated
through the introduction of new f ixed-rate accounts. also contributed to the overaLI upLift in
funding. Together, these factors enabled us to achieve higher income than in 2024.
Membership income (£8.400) was up on 2024 (£7.74fl) due to the increase in retention.
PrincipaL Expenditure
TotaL charitable expenditure in 2025 was £182.859, compared with £138,899 in 2024. This
increase refLects the growth in charitable activity, incLuding an increase in the number of
webinar5 delivered. additionaL online Learning modules produced. a new regional meeting
was held, increased travel bursaries awarded, and higher committee costs (the committee
has returned to face-to-face meetings rather than virtuaL formats). The national conference
was aLso significantly more expensive in 2025 than in 2024, driven by substantial rises in
venue fees that exceeded current inf lation rates.
Support costs have risen by £15,201 in the fiscal year to £33,913. The largest item in support
costs was secretariat, website and accountancy costs, which includes fees paid to Red Hot
Irons. Red Hot I rons is contracted to run the day-to-day operations of the charity, including
maintenance and upkeep of our website, membership management and communications,
committee management, events, IT, webinar5, anaLytics and database.
Reserves Policy
LCNUK has no regular or guaranteed sources of income, and the Long-term financial
sustainabi lity of the charity remains uncertain. Despite this, the charity must meet f ixed
operating costs to maintain its activities, fulf IL its charitabLe objectives, and sustain its
presence. Work is planned at least one year in advance, with some financiaL commitments -
such as those relating to the annual conference- made up to two years ahead.
The Trustees have therefore determined that, in order to safeguard the delivery of
programmes in the event of a significant reduction in income, the charity should hold an
opti mal reserve equivalent to 12 months of f ixed operating costs plus the annual cost of the
conference.
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011)
12

Trustees, Report | For the year ending January 2026
This level of reserve enables LCNU K to pursue its long-term strategy without being forced into
short-term reactive decisions during temporary funding deficits. It also provides the flexi bility
to take forward new opportunities that may require modest upfront investment. Minimum and
maximum reserve Levels have been set at six months and eighteen months of operating costs
respectively.
The Trustees will only consider taking significant corrective action if reserves fall below the
minimum threshoLd. and WILL onLy commit to major Long-term investments when reserves
exceed the optimaL leveL.
Based on the 2026 budget. the optimal reserve level is £226.664. with a minimum requirement
of £113,332. At the end of the accounting period (January 2026), the Society held free reserves
of £442,048, exceeding the optimal reserve target. The Board is now working with the
committee to identify new and appropriate charitabLe-purpose programmes that can be
supported using the surpLus reserves.
The Board undertakes an annual review of the reserves policy to ensure it remains aLigned
with the charity's activities and that the level of reserves is suff icient to meet f inancial and
charitable obligations should funding decline for any reason.
Going concern
After making appropriate enquiries. the Trustees have a reasonable expectation that the
charity has adequate resources to continue in operationaL existence for the foreseeabLe
future. For this reason, they continue to adopt the going concern basis in preparing the
financial statements. Further detaiLs regarding the adoption of the going concern basis can be
found in the accounting policies.
Financial Review Conclusion
The Society ended the year with an operating surplus of £38,280 for the accounting period.
The charity continues to hold healthy free reserves which exceed the maximum reserves Level
allowing the charity to undertake additional charitabLe programmes.
However, sponsorship and funding remain a significant challenge and operating costs
continue to rise particularly around venue hire charges and insurance costs. The Trustees
recognise that the funding situation remains chalLenging, and WILL continue to be innovative in
our approach to fundraising, cost savings and ensuring value for money. We WILL also Look to
achieve additionaL funding from grant making bodies.
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}
13

Trustees, Report | For the year ending January 2026
Statement of Trustees, responsibilities
The Trustees are responsibLe for preparing the Trustees, report and the financiaL statements in
accordance with applicable law and United Kingdom Accounting Standards (United Kingdom
Generally Accepted Accounting Practice).
Charity law requires the Trustees to prepare financial statements for each financiaL year.
Under charity law the Trustees must not approve the financial statements unless they are
satisfied that they give a true and fai r view of the state of affairs of the Charity and of its
incoming resources and application of resources, i ncluding its income and expenditure, for
that period. In preparing these financial statements, the Trustees are required to:
seLect suitabLe accounting policies and then apply them consistently:
observe the methods and principles of the Charities SORP (FRS 102)-
make judgments and accounting estimates that are reasonable and prudent,.
state whether applicable UK Accounting Standards {FRS 102) have been followed, subject
to any materiaL departures d isclosed and explained in the f inancial statements,.
prepare the financial statements on the going concern basis unless it is inappropriate to
presume that the charity will continue in business.
The Trustees are responsible for keeping adequate accounting records that are sufficient to
show and expLain the charity's transactions and discLose with reasonable accuracy at any time
the financiaL position of the charity and enabLe them to ensure that the f inancial statements
comply with the Charities Act 2011. They are aLso responsible for safeguarding the assets of
the charity and hence for taking reasonable steps for the prevention and detection of fraud
and other irreguLarities.
Disclosure of information to independent examiners
Each of the persons who are Trustees at the time when this Trustees, report is approved has
conf irmed that..
so far as that Trustee is aware, there is no relevant information of which the charity's
accountant and independent examiner are unaware, and
that Trustee has taken alL the steps that ought to have been taken as a Trustee in order to
be aware of any reLevant information and to establish that the charity's accountants are
aware of that information.
Approved by order of the members of the board of Trustees and signed on their behalf by..
Dominic Smith
Interim Chair of the Board of Trustees
Date..
Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011)
14

## **Independent Examiner's Report to the Trustees of** 

## **Lung Cancer Nursing UK** 

I report on the accounts of the charity for the year ended 31 January 2026, which are set out on pages 16 to 23. 

Your attention is drawn to the fact that the Charity has prepared the financial statements in accordance with Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) in preference to the Accounting and Reporting by Charities: Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extant regulations but has since been withdrawn. 

We understand that this has been done in order for the accounts to provide a true and fair view in accordance with the Generally Accepted Accounting Practice effective for reporting periods beginning on or after 1 January 2019. 

## **Respective responsibilities of trustees and examiner** 

The Charity's trustees are responsible for the preparation of the accounts. The trustees consider that an audit is not required for this year under section 144(2) of the Charities Act 2011 as amended by the Charities Act 2022 (the Act) and that an independent examination is needed. 

The charity's gross income exceeded £250,000 and I am qualified to undertake the examination by being a qualified member of the Institute of Chartered Accountants in England and Wales. 

It is my responsibility to: 

- examine the accounts under section 145 of the Act; 

- follow the procedures laid down in the General Directions given by the Charity Commission under section 145 (5) (b) of the Act; and 

- state whether particular matters have come to my attention. 

## **Basis of independent examiner's report** 

My examination was carried out in accordance with the General Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts, and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit and consequently no opinion is given as to whether the accounts present a 'true and fair view' and the report is limited to those matters set out in the statement below. 

## **Independent examiner's statement** 

In connection with my examination, no matter has come to my attention: 

- (1) which gives me reasonable cause to believe that in any material respect the requirements: 

   - to keep accounting records in accordance with section 130 of the Charities Act 2011 as amended by the Charities Act 2022; and 

   - to prepare accounts which accord with the accounting records, comply with the accounting requirements of the Act 

have not been met; or 

- (2) to which, in my opinion, attention should be drawn in order to enable a proper understanding of the accounts to be reached. 


**----- Start of picture text -----**<br>
.........................................<br>**----- End of picture text -----**<br>


......................................... Joanne Thomlinson FCA Dodd & Co Limited Chartered Accountants 

FIFTEEN Rosehill Montgomery Way Rosehill Estate CARLISLE CA1 2RW 

26 May 2026 

Page 15 



Lung Cancer Nursing UK
known as
LCNUK
Statement of Financial Activities for the Year Ended 31 January 2026
Unrestricted Total Fund¥ Totsl Fund¥
Funds
2026
2025
Note
Income and endowments from:
Donations and legacies
Investtnenl income
Charitable activities
Total income
114
19,820
235.118
255,052
114
19,820
235.118
255.052
6,808
225.996
232,804
Expenditure on:
Ch8rit8ble activities
Total expenditure
216,772
216.772
216,772
218.772
157,611
157.611
Nel movements in funds
38,280
38,280
75,193
Reconciliation of funds
Total funds brought forward
Total funds carried forward
403,768
442,048
403,788
442,048
328,575
403,768
The notes on pages 18 10 24 form integral part of these fin8ncial staleTnent5.
Page 16

Lung Cancer Nursing UK
trading as
LCNUK
Balance Sheet as at 31 January 2026
2026
2025
Note
Current assets
Debtors
Cash at bank and in hand
10
49,693
442.451
58,401
375.181
492,144
433,582
Creditors.. Amounts falling du• within
one year
150,0961
{29,8141
Net current assets
442,048
403,768
Net assets
442,048
403,768
The funds of the charity=
Unrestricted funds
Unre51ricted income funds
442,048
403,768
Total charity funds
442,048
403,768
The financial statements have been prepared in accordance with the Financial Reporting Standard applicable in
the UK and Republic of Ireland IFRS 1021.
ApDroved by the Board on 26 May 2026 and signed on its behalf by..
D Smith
Trustee
The notes on pages 18 to 24 fomi an integral part of these financial ststements.
Page 17

Lung Cancer Nursing UK
known as
LCNUK
Notes to the Financial Statements for the Year Ended 31 January 2026
Accounting policies
Statèmant of eomplianeè
The accounts (financial statements) have been prepared under the historical cost convention with items
recognised at cost or transaction value unless otherwise stated in the relevant notelsl to these accounts.
The financial statements have been prepared in accordance wth the second edition of the Charities
Statement of Recommended Practice issued in October 2019, the Financial Reporting Standard applicable
in the United Kingdom and Republic of Ireland IFRS 1021 and the Charities Act 2011 as amended by the
Charities Act 2022.
The accounts Ifinancial statements) have been prepared to give a 'true and fairf view and have departed
from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a 'true
and fair view,. This departure has involved following Accounting and Reporting by Charities preparing their
accounts in accordan￿ with the Finanaal Reporting Standard applicable in the UK and Republic of Ireland
IFRS 1021 rather than the Accounting and Reporting by Charities'.Statement of Recommended Practice
effective from 1 April 2005 which has since been withdrawn.
Basis of preparation
The charity meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially
recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy
notes.
Going concern
These financial statements have been prepared on a going concern basis.The trustees assess whether the
use of going con￿rn is appropriate i.e. whether there are any material uncertainties related to events or
conditions that may cast significant doubt on the ability ol the Charity to continue as a going concern. The
trustees make this assessment in respect of a period of one year from the date of approval of the financial
statements.
Fund accounting policy
Unrestricted income funds are general funds that are available for use at the trustees, discretion in
furtherance of the objectives of the charity.
Further details ol each fund are disclosed in note 13.
Income and endowments
Donations and legacies induding gifts are recognised where there is entitlement, probability of receipt and
the amount can be measured with sufficient reliability.
Income frorn Goveinmenl and other grants, whelher'¢apilal' grants or'revenue, grants, is recognised when
the charity has entitlement to the fLJnd5. any performance conditions 8ttached to the grants have been mel,
It Is piobable th8t the incotne will be received and the atnount be rneasured reliably and 15 not deferred.
Investment income is recognised on a receivable basis.
Income from charitable activities includes income recognised as earned las the related goods or services
are provided) under contract.
Membership income is recognised in the period it relates to.
Page 18

Lung Cancer Nursing UK
known as
LCNUK
Notes to the Financial Statements for the Year Ended 31 January 2026
. conh"rtued
Expenditure
Liabilities are recognised as soon as there is a legal or constructive obligation committing the charity to the
expenditure. All expenditu￿ is accounted for on an accruals basis and has been dassrfied under headings
that aggregate all costs related to the category.
Expenditure on raising funds are the ￿sts of trading for fundraising purposes.
Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and
services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those
costs of an indirect nature necessary to support them.
Grants payable are payments made to third parties in the furtherance of the charitable objectives. Where
the charity gives a grant with conditions ft>r its payment being a speerfic level ol service or output to be
provided, such grants are only recognised in the SOFA once the reapient of the grant has provided the
specific service or output.
Grants payable without performance conditions are only recognised In the accounts when 8 Commitment
has been made and there are no conditions to be mel relating to the grant which rernain in the conliol of the
charity.
Provisions for grants are made when the intention lo m8ke a gr8nt has been communicated to the recipient
but there is uncertainty about either the timing of the grant or the amount of grant payable.
Support costs
Support costs include central functions and have been allocated to activity cost categories on a basis
consistent with the use of resources, for example. allocating propety costs by floor areas, or per c8Pita,
stsff costs by the lirne spent and other costs by their usage.
Irrecoverable VAT
Irrecoverable VAT is charged against the category of resources expended for which il was incurred.
Cash and Cash Equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-lemi highly liquid
investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of
change in value.
Restatement of comparatives
The charity has reclassified certain income items from donations and legacies to charitable activities
following a review of income presentation.
This is a disdosur&only change and does not affect total income, net rnovement in funds, or the charity's
financi81 position. Prior year comparatives have been reslaled accordingly lo ensure consistency wth the
current yearfs presentation.
Page 19

Lung Cancer Nursing UK
known as
LCNUK
Notes to the Financial Statements for the Year Ended 31 January 2026
. conh"rtued
Donatlons and legaeles
Unrestrictad Total Funds Total Funds
Funds
2026
2025
Donations and lègaciès
Donations
114
114
In¥astm•nt ineomè
Unr•striet•d Total Funds Total Funds
Funds
2026
2025
Interest on cash deposits
19,820
19.820
6,808
01 the investment income in 2025 £e,808 related to unrestricted funds.
Charitable activities
Unrestricted Total Funds Totsl Funds
Funds
2026
2025
Membershlp and research
Membership subscriptions
Corporate sponsorship
Regional incotne
Navigator group income
8,400
12.000
3,950
17
24,367
8,4QO
12.000
3,950
7,740
22.000
24.367
29,740
Annual conference
Conference sponsorship
collferen￿ exhibition only
Delegate registration
143,578
22,455
32.018
198,051
143.578
22,455
32,018
198,051
140,845
19,618
30,793
191,256
Online Education
Leadership programme income
Online Eduration Learning Modules
Webinar Sponsorship
5.000
7,700
5,000
12,700
7,700
5,000
12.700
5,000
235,118
235.118
225,996
Page 20

Lung Cancer Nursing UK
known as
LCNUK
Notes to the Financial Statements for the Year Ended 31 January 2026
. conh"rtued
Of the incorne from tharilable activities in 2025 £225,996 related lo unreslrided funds.
Expendlture
Membershlp
and
research
Annual
conference
Onllne
Educatlon
Total
2026
Total
2025
Direct costs
Grants payable- individuals
Webin81 Costs
Leadership progratnrne
expenditure
Metnber5hip administration costs
TSG committee costs
Website costs
N8vigalor group expenditure
RIG costs
Annual workshop
Online learning
Venue costs
Speaker costs and tokens
Management fees
Conlerence costs- materials
Conference costs- other
2,649
2.649
7,123
4,134
12,299
845
6.940
8,595
998
998
19841
5,846
4,455
12,533
1,061
4,328
570
1,936
8,333
2,708
43.664
3,444
11,500
20,068
19,437
138.899
7,123
4,134
12,299
845
6.940
8,595
998
998
80.559
80.559
2,946
12,000
23.724
19,049
182,859
12,000
23,724
19,049
140,927
30.675
11,257
Support costs
Insurance
Office management
Committee costs
Representation costs
Sundry expenses
Accountancy and bookkeeping
fees
Independent examinerfs fee
Bank charges
285
5,026
3.439
279
285
5,026
3,438
278
285
5,026
3,438
278
104
855
15,078
10,315
835
312
828
7,591
3,055
324
1.754
1,754
1.754
5.262
4,835
650
1,429
18,712
216
202
11,305
217
202
11,304
217
202
11,304
650
606
33,913
41,980
152,231
22,561
218,772
157,611
Of the total expendituie in 2025 £157,611 related to unrestricted funds.
Page 21

## **Lung Cancer Nursing UK known as LCNUK** 

## **Notes to the Financial Statements for the Year Ended 31 January 2026** 

_......... continued_ 

## **6 Grantmaking** 

## **Grants to individuals £** 

Annual conference 

2,649 

## **7 Trustees' remuneration and expenses** 

Committee meeting and travel expenses totalling £283 (2025: £387) were paid to 2 (2025: 4) of the trustees during the year. 

## **8 Taxation** 

The registered charity is exempt from taxation on income and gains. 

## **9 Debtors** 

|Trade debtors<br>Other debtors<br>Prepayments and accrued income|**2026**<br>**£**<br>22,774<br>1,140<br>25,779<br>49,693|**2025**<br>**£**<br>-<br>7,453<br>50,948|
|---|---|---|
|||58,401|



## **10 Creditors: Amounts falling due within one year** 

|Trade creditors<br>Other creditors<br>Accruals and deferred income|**2026**<br>**£**<br>2,664<br>-<br>47,432<br>50,096|**2025**<br>**£**<br>1,787<br>340<br>27,687|
|---|---|---|
|||29,814|



## **11 Related parties** 

## **Controlling entity** 

The charity is controlled by the trustees. 

Page 22 



## **Lung Cancer Nursing UK known as LCNUK** 

## **Notes to the Financial Statements for the Year Ended 31 January 2026** 

_......... continued_ 

## **12 Analysis of funds** 

|**General Funds**<br>Unrestricted income fund<br>**Prior year**<br>**General Funds**<br>Unrestricted income fund|**At 1**<br>**February**<br>**2025**<br>**Incoming**<br>**resources**<br>**Resources**<br>**expended**<br>**£**<br>**£**<br>**£**<br>403,768<br>255,052<br>(216,772)<br>**At 1**<br>**February**<br>**2024**<br>**Incoming**<br>**resources**<br>**Resources**<br>**expended**<br>**£**<br>**£**<br>**£**<br>328,575<br>232,804<br>(157,611)|**At 31**<br>**January 2026**<br>**£**<br>442,048|
|---|---|---|
|||**At 31**<br>**January 2025**<br>**£**<br>403,768|



## **13 Net assets by fund** 

|Current assets<br>Creditors: Amounts falling due within one year<br>Net assets<br>**Prior year**<br>Current assets<br>Creditors: Amounts falling due within one year<br>Net assets|**Unrestricted**<br>**Funds**<br>**£**<br>492,144<br>(50,096)<br>442,048<br>**Unrestricted**<br>**funds**<br>**£**<br>433,582<br>(29,814)<br>403,768|**Total Funds**<br>**2026**<br>**£**<br>492,144<br>(50,096)<br>442,048<br>**Total funds**<br>**2025**<br>**£**<br>433,582<br>(29,814)<br>403,768|**Total Funds**<br>**2025**<br>**£**<br>433,582<br>(29,814)<br>403,768<br>**Total funds**<br>**2024**<br>**£**<br>386,310<br>(57,735)<br>328,575|
|---|---|---|---|



Page 23 



LUNG
CANCER
NURSING
UK
WWW.LCNUK.ORG
Phone: 01675 477607
EmaiL' info@lcnuk.org
Correspondence address:
483 Green Lanes
London
N13 4BS
•V
Lung Cancer Nursing UK is a charitable incorporated organisation
Charity number 1160011